DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY TRADE DATA ANALYSIS
Discover Online Profitable Buyers, Suppliers, Markets, Products and Monitor Competition From Over 100+ Countries In Single Subscription
DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY – Overview
DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY is a foremost import company in Vietnam. We provide a supply chain intelligence report of DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY that covers company profile, top imports, foreign suppliers, ports used, etc. The Import data of DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY is driven from Vietnam import marine time database, government authorities, and other sources of the Vietnam. We update data regularly and provide latest and updated Import Data.
We provide an online customized Vietnam Importers Data dashboard where traders can analyse competitors, Vietnam importers, overseas suppliers and exporters, top imported products, importing partners etc. DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY can analyse trade relations and sourcing for buyers by time like monthly, yearly.
DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY has customized dashboard for Vietnam importers. Also they provide demo data search and you can search and analyse all available data records in this. You can download Import data set by selecting them.
Import Shipments15
Buyers15
Export Shipments0
Suppliers0
Website
***********
Email address
***********
Phone number
***********
LinkedIn
***********
CEO
***********
Director
***********
Head-Purchase
***********
Head-Sales
***********
DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY automation import markets
Based on Vietnam Countries shipment data.
If you are looking to establish relationship with DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY Automation you can save time by getting access to the key decision makers and get a detailed report.
DONGNAI PHARMACEUTICAL JOINT STOCK COMPANY Import Market
15 Import Shipments found from 15 importing countries.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. | More Columns Click to View |
|---|---|---|---|---|---|---|---|
| 29242990 | RAW. MATERIALS FOR DRUG PRODUCTION:LIDOCAINE HCL USP 43 LO: MC/LH/0151/22 NSX:12/2022 HD:11/2027 SERIAL NUMBER:VD-31301-18 NSX: MAHENDRA CHEMICALS |  |
|
INDIA | Vietnam | 150 | 60 More Columns Available |
| 29419000 | RAW. MATERIALS FOR DRUG PRODUCTION:CEFUROXIME AXETIL (AMORPHOUS) USP43 LO:CAAN220701;CAAN230003 NSX:12/2022;01/2023 HD:11/2025;DECEMBER 2025 PRODUCT NUMBER:VD-35468-21 NSX: COVALENT LABORATORIES PRIVATE LIMITED | |
|
INDIA | Vietnam | 500 | |
| 29419000 | STA.NDARD NIZATIDINE PHARMACEUTICAL INGREDIENTS : USP 43 , NSX : SOLARA ACTIVE PHARMA SCIENCES , 100% BRAND NEW | |
|
INDIA | Vietnam | 0.1 | |
| 29349990 | RAW. MATERIALS FOR DRUG PRODUCTION: RIVAROXABAN MANUFACTURER STANDARD BATCHES:109-20220901S;109-20220901S;NSX:09;12/08/2022;HD:08;11/08/2025;SDK:VD-35779-22; NSX:JIANGXI SYNERGY PHARMACEUTICAL CO.,LTD | |
|
CHINA | Vietnam | 5 | |
| 29339990 | RAW. MATERIALS FOR DRUG PRODUCTION:RAMIPRIL EP 10.0 LO:RI-22258 NSX:11/2022;HD:10/2027 DR:VD-31783-19;NSX:AARTI INDUSTRIES LIMITED | |
|
INDIA | Vietnam | 20 | |